Bellicum Pharmaceuticals
Earnings Date & Report
Last updated:
Bellicum Pharmaceuticals’s last earnings date was on 29 Mar 2024.
Bellicum Pharmaceuticals stock Earnings report, Estimates & History
| 2019-08-05 | -6.22978 | -5.8 |
|---|---|---|
| 2019-11-06 | -8.7244 | -6.8 |
| 2020-03-12 | -8.4681 | -5.82 |
| 2020-05-07 | -0.43524 | 1.09 |
| 2020-08-06 | -25.91724 | -9.29 |
| 2020-11-05 | -0.0103 | -0.18 |
| 2021-03-30 | -0.90601 | 0.98 |
| 2021-05-17 | -0.85136 | -1.08 |
| 2021-08-12 | -0.03533 | -0.22 |
| 2021-11-04 | 0.07 | 0.07 |
| 2022-03-24 | -0.03025 | 0.11 |
| 2022-05-12 | -0.09327 | -0.25 |
| 2022-08-11 | -0.02449 | -0.13 |
| 2022-11-10 | -0.08266 | -0.23 |
| 2023-03-24 | -0.93 | -0.27 |
| 2023-05-11 | -0.19882 | -0.26 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Bellicum Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 29 Mar 2024 | N/A | N/A | N/A | N/A | N/A | |
| 8 Nov 2023 | N/A | N/A | N/A | N/A | N/A | |
| 9 Aug 2023 | N/A | -$0.09 | N/A | N/A | N/A | |
| 11 May 2023 | Missed | -$0.2 | -$0.26 | N/A | 8K | |
| 24 Mar 2023 | Beat | -$0.93 | -$0.27 | N/A | 500K | |
| 31 Dec 2022 | N/A | N/A | -$1.08 | N/A | 500K | |
| 10 Nov 2022 | Missed | -$0.08 | -$0.23 | N/A | 1M | |
| 11 Aug 2022 | Missed | -$0.02 | -$0.13 | N/A | N/A | |
| 12 May 2022 | Missed | -$0.09 | -$0.25 | N/A | N/A | |
| 24 Mar 2022 | Beat | -$0.03 | $0.11 | 250K | -11.38M | |
| 4 Nov 2021 | Matched | $0.07 | $0.07 | 250K | 5M | |
| 12 Aug 2021 | Missed | -$0.04 | -$0.22 | 250K | 700K | |
| 17 May 2021 | Missed | -$0.85 | -$1.08 | N/A | N/A | |
| 30 Mar 2021 | Beat | -$0.91 | $0.98 | N/A | N/A | Earnings Call Transcript |
| 5 Nov 2020 | Missed | -$0.01 | -$0.18 | 72.85M | N/A | |
| 6 Aug 2020 | Beat | -$25.92 | -$9.29 | 1.46M | N/A | Earnings Call Transcript |
| 7 May 2020 | Beat | -$0.44 | $1.09 | 10.44M | N/A | |
| 12 Mar 2020 | Beat | -$8.47 | -$5.82 | 3.52M | 5.13M | Earnings Call Transcript |
| 6 Nov 2019 | Beat | -$8.72 | -$6.8 | 80.27K | 103K | Earnings Call Transcript |
| 5 Aug 2019 | Beat | -$6.23 | -$5.8 | 1.29M | 1.39M | |
Bellicum Pharmaceuticals Earnings report FAQs
When is Bellicum Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Bellicum Pharmaceuticals's earnings date was on 24 Mar 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.